Cover Image
市場調查報告書

中國的分子診斷市場、檢查數量的預測

China Molecular Diagnostics Market, Test Volume & Forecast By Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)

出版商 Renub Research 商品編碼 344768
出版日期 內容資訊 英文 105 Pages; 55 Figures; 14 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的分子診斷市場、檢查數量的預測 China Molecular Diagnostics Market, Test Volume & Forecast By Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)
出版日期: 2017年08月28日 內容資訊: 英文 105 Pages; 55 Figures; 14 Tables
簡介

中國的中分子診斷部門是10億美元規模的產業,年年迅速發展。在國內未來市場中隱藏著非常大的可能性,預計從2015年到2019年,將進行3億件以上的分子診斷檢驗。

本報告提供中國的分子診斷的市場相關調查、市場規模及檢查數量的變化與預測、各用途的詳細分析、市場成長的推進因素及課題分析、主要經營者簡介等彙整資料。

第1章 摘要整理

第2章 中國的分子診斷市場、檢查數量的預測

  • 中國的分子診斷市場變化與預測
  • 中國的分子診斷檢查數量的變化與預測

第3章 中國的分子診斷市場、檢查數量的市場佔有率分析

  • 中國的分子診斷市場佔有率:變化與預測
  • 各用途佔有率的變化與預測
  • 中國的分子診斷的檢查數量的市場佔有率:變化與預測
  • 各檢查數量用途佔有率:變化與預測

第4章 中國的分子診斷檢查數量的變化與預測:各用途

  • 癌症的分子診斷檢查數量的佔有率:變化與預測
  • 癌症檢查數量的變化與預測
    • 乳癌
    • 直腸癌
    • 前列腺癌
  • 感染疾病的分子診斷檢查數量的佔有率:變化與預測
  • 傳染病檢查數量的變化與預測
    • 病毒檢驗
    • HPV檢驗
  • 遺傳基因的分子檢查數量的佔有率:變化與預測
  • 遺傳基因檢查數量的變化與預測
    • 血液篩檢檢驗
    • HLA檢驗

第5章 中國的分子診斷市場預測:各用途

  • 癌症的分子診斷檢驗市場佔有率:變化與預測
  • 癌症檢驗市場變化與預測
    • 乳癌
    • 直腸癌
    • 前列腺癌
  • 感染疾病的分子診斷檢驗市場佔有率:變化與預測
  • 傳染病檢查市場變化與預測
    • 病毒檢驗
    • HPV檢驗
  • 遺傳基因的分子診斷檢驗市場佔有率:變化與預測
  • 遺傳基因檢驗市場變化與預測
    • 血液篩檢檢驗
    • HLA檢驗

第6章 成長推進因素

  • 中產階級對高品質醫療保健產品的需求擴大
  • 中國的感染疾病診斷領域的急劇發展

第7章 課題

  • 政府支援不足、一般認知度低、償付方案的未整備
  • 有技術的人力資源不足

第8章 主要民間臨床實驗室、診斷服務企業簡介

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (民間)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (民間)
  • BGI-Shenzhen
  • OriGene Technologies
    • 企業概要
    • 產品與服務

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

China molecular diagnostics market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.

China Molecular Diagnostics Segments Market

China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.

This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled "China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) " provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market. This 105 page report with 55 Figures and 14 Tables studies the China Molecular Diagnostic market from 4 view points:

  • 1. Market & Forecast
  • 2. Molecular Diagnostics Segments Market & Forecast
  • 3. Molecular Diagnostics Segments Test Volume & Forecast
  • 4. Profiles of Select Private Clinical Labs & Diagnostic Services Companies

Segments Covered in this report are as follows:

Oncology Test Market and Volume

  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer

Infectious Disease Test Market and Volume

  • Virology
  • HPV

Genetic Test Market and Volume

  • Blood Screening
  • HLA

Key Players Analysis

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

Key questions answered in the study

  • What is China molecular diagnostics market size from 2011 to 2022?
  • What is China molecular diagnostics tests volume from 2011 to 2022?
  • What are China molecular diagnostics segments market & Forecast?
  • What are the growth drivers of Molecular diagnostics in China?

Table of Contents

1. Research Findings

2. China Molecular Diagnostic Market & Test Volume Forecast

  • 2.1 China Molecular Diagnostic Market
  • 2.2 China Molecular Diagnostic Test Volume

3. China Molecular Diagnostic Market Share Analysis

  • 3.1 Market Share - (Oncology, Infectious, Genetic) Testing
  • 3.2 Market Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

4. China Molecular Diagnostic Volume Share (2011 - 2022)

  • 4.1 Volume Share - (Oncology, Infectious, Genetic) Testing
  • 4.2 Volume Share - Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

5. Segments Test Volume - China Molecular Diagnostics

  • 5.1 Volume Share - (Breast, Colorectal, Prostate) Oncology Test
  • 5.2 Oncology Test Volume
    • 5.2.1 Breast Cancer Test Volume
    • 5.2.2 Colorectal Cancer Test Volume
    • 5.2.3 Prostate Cancer Test Volume
  • 5.3 Volume Share - (Virology, HPV) Infectious Disease Test
  • 5.4 Infectious Disease Test Volume
    • 5.4.1 Virology Test Volume
    • 5.4.2 HPV Test Volume
  • 5.5 Volume Share - (Blood Screening, HLA) Genetic Test
  • 5.6 Genetic Test Volume
    • 5.6.1 Blood Screening Test Volume
    • 5.6.2 HLA Test Volume

6. Segments Test Market - China Molecular Diagnostics Market (2011 - 2022)

  • 6.1 Market Share - (Breast, Colorectal, Prostate) Oncology Test
  • 6.2 Oncology Test Market
    • 6.2.1 Breast Cancer Test Market
    • 6.2.2 Colorectal Cancer Test Market
    • 6.2.3 Prostate Cancer Test Market
  • 6.3 Market Share - (Virology, HPV) Infectious Disease Test
  • 6.4 Infectious Disease Test Market
    • 6.4.1 Virology Test Market
    • 6.4.2 HPV Test Market
  • 6.5 Market Share - (Blood Screening, HLA) Genetic Test
  • 6.6 Genetic Test Market
    • 6.6.1 Blood Screening Market
    • 6.6.2 HLA Test Market

7. China Healthcare Insurance Schemes

  • 7.1 China Healthcare Insurance Schemes
    • 7.1.1 NRCMS
    • 7.1.2 UEBMI
    • 7.1.3 URBMI
    • 7.1.4 Private Health Insurance
    • 7.1.5 Cost-sharing and out-of-pocket Spending

8. Growth Drivers

  • 8.1 Rising Order for High Quality Healthcare Products
  • 8.2 Growing Cases of Lifestyle Diseases
  • 8.3 Rapid Diagnosis of Infectious Diseases
  • 8.4 Rise in Number of Private Hospitals & Independent Diagnostics Clinics
    • 8.4.1 Rise in the Number of Hospital Beds across all Medical Institutions
  • 8.5 Increasing Automation

9. Challenges

  • 9.1 Nil Government Support & Public Awareness
  • 9.2 Dearth of Trained Medical Technicians
  • 9.3 Reimbursement Rates differ from Province to Province in China
    • 9.3.1 Chinese Government Regulating Laboratory Testing in China

10. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 10.1 Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 10.1.1 Company Overview
    • 10.1.2 Products and Services Offered by Di'an
  • 10.2 ADICON Clinical Laboratories (Privately held)
    • 10.2.1 Company Overview
    • 10.2.2 Products and Services Offered by ADICON
  • 10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Products and Services Offered by Kingmed
  • 10.4 Kindstar Global (Privately held)
    • 10.4.1 Company Overview
    • 10.4.2 Products and Services Offered by Kindstar
  • 10.5 BGI-Shenzhen
    • 10.5.1 Company Overview
    • 10.5.2 BGI's Innovative Approach
  • 10.6 OriGene Technologies
    • 10.6.1 Company Overview
    • 10.6.2 Products and Services Offered by OriGene

List of Figures

  • Figure 2-1: China - Molecular Diagnostic Market (Million US$), 2011 - 2016
  • Figure 2-2: China - Forecast for Molecular Diagnostic Market (Million US$), 2017 - 2022
  • Figure 2-3: China - Molecular Diagnostic Test Volume (Million), 2011 - 2016
  • Figure 2-4: China - Forecast for Molecular Diagnostic Test Volume (Million), 2017 - 2022
  • Figure 3-1: China - Molecular Diagnostic Market Share (Percent), 2011 - 2016
  • Figure 3-2: China - Forecast for Molecular Diagnostic Market Share (Percent), 2017 - 2022
  • Figure 3-5: China - Molecular Diagnostic Test Volume Share (Percent), 2011 - 2016
  • Figure 3-6: China - Forecast for Molecular Diagnostic Test Volume Share (Percent), 2017 - 2022
  • Figure 4-1: China - Molecular Oncology Test Volume Share (Percent), 2011 - 2016
  • Figure 4-2: China - Forecast for Molecular Oncology Test Volume Share (Percent), 2017 - 2022
  • Figure 4-3: Rural China - Cancer Screening Sites by Cancer Type (Number), 2013
  • Figure 4-4: China - Oncology Test Volume (Million), 2011 - 2016
  • Figure 4-5: China - Forecast for Oncology Test Volume (Million), 2017 - 2022
  • Figure 4-6: China -Breast Cancer Molecular Test Volume (Million), 2011 - 2016
  • Figure 4-7: China - Forecast for Breast Cancer Molecular Test Volume (Million), 2017 - 2022
  • Figure 4-8: China -Colorectal Cancer Test Volume (Million), 2011 - 2016
  • Figure 4-9: China - Forecast for Colorectal Cancer Test Volume (Million), 2017 - 2022
  • Figure 4-10: China -Prostate Cancer Test Volume (Million), 2011 - 2016
  • Figure 4-11: China - Forecast for Prostate Cancer Test Volume (Million), 2017 - 2022
  • Figure 4-14: China -Infectious Disease Test Volume (Million), 2011 - 2016
  • Figure 4-15: China - Forecast for Infectious Disease Test Volume (Million), 2017 - 2022
  • Figure 4-16: China -Virology Test Volume (Million), 2011 - 2016
  • Figure 4-17: China - Forecast for Virology Test Volume (Million), 2017 - 2022
  • Figure 4-18: China -HPV Test Volume (Thousand), 2011 - 2016
  • Figure 4-19: China - Forecast for HPV Test Volume (Thousand), 2017 - 2022
  • Figure 4-22: China -Genetic Test Volume (Million), 2011 - 2016
  • Figure 4-23: China - Forecast for Genetic Test Volume (Million), 2017 - 2022
  • Figure 4-24: China -Blood Screening Test Volume (Million), 2011 - 2016
  • Figure 4-25: China - Forecast for Blood Screening Test Volume (Million), 2017 - 2022
  • Figure 4-26: China - HLA Test Volume (Thousand), 2011 - 2016
  • Figure 4-27: China - Forecast for HLA Test Volume (Thousand), 2017 - 2022
  • Figure 5-1: China - Molecular Oncology Test Market Share (Percent), 2011 - 2016
  • Figure 5-2: China - Forecast for Molecular Oncology Test Market Share (Percent), 2017 - 2022
  • Figure 5-3: China -Oncology Test Market (Million US$), 2011 - 2016
  • Figure 5-4: China - Forecast for Oncology Test Market (Million US$), 2017 - 2022
  • Figure 5-5: China -Breast Cancer Test Market (Million US$), 2011 - 2016
  • Figure 5-6: China - Forecast for Breast Cancer Test Market (Million US$), 2017 - 2022
  • Figure 5-7: China -Colorectal Cancer Test Market (Million US$), 2011 - 2016
  • Figure 5-8: China - Forecast for Colorectal Cancer Test Market (Million US$), 2017 - 2022
  • Figure 5-9: China -Prostate Cancer Testing Market (Million US$), 2011 - 2016
  • Figure 5-10: China - Forecast for Prostate Cancer Testing Market (Million US$), 2017 - 2022
  • Figure 5-13: China -Infectious Disease Test Market (Million US$), 2011 - 2016
  • Figure 5-14: China - Forecast for Infectious Disease Test Market (Million US$), 2017 - 2022
  • Figure 5-15: China -Virology Test Market (Million US$), 2011 - 2016
  • Figure 5-16: China - Forecast for Virology Test Market (Million US$), 2017 - 2022
  • Figure 5-17: China -HPV Test Market (Million US$), 2011 - 2016
  • Figure 5-18: China - Forecast for HPV Test Market (Million US$), 2017 - 2022
  • Figure 5-21: China -Genetic Testing Market (Million US$), 2011 - 2016
  • Figure 5-22: China - Forecast for Genetic Testing Market (Million US$), 2017 - 2022
  • Figure 5-23: China -Blood Screening Market (Million US$), 2011 - 2016
  • Figure 5-24: China - Forecast for Blood Screening Market (Million US$), 2017 - 2022
  • Figure 5-25: China - HLA Test Market (Thousand US$), 2011 - 2016
  • Figure 5-26: China - Forecast for HLA Test Market (Thousand US$), 2017 - 2022
  • Figure 6-1: China - Healthcare Spending (Billion US$), 2011 &2020
  • Figure 8-1: Kindstar - Collaboration with Hospitals in China (Number), 2006-2012

List of Tables

  • Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2016
  • Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2017 - 2022
  • Table 3-3: China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2016
  • Table 3-4: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2017 - 2022
  • Table 4-1: China - Molecular Infectious Disease Test Volume Share (Percent), 2011 - 2016
  • Table 4-2: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2017 - 2022
  • Table 4-3: China - Molecular Genetic Test Volume Share (Percent), 2011 - 2016
  • Table 4-4: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2017 - 2022
  • Table 5-1: China - Molecular Infectious Disease Test Market Share (Percent), 2011 - 2016
  • Table 5-2: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2017 - 2022
  • Table 5-3: China - Molecular Genetic Test Market Share (Percent), 2011 - 2016
  • Table 5-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2017 - 2022
  • Table 6-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
  • Table 8 1: Number of Hospital Beds for every 1,000 people
Back to Top